Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Presently there are 48 participants in this study and the estimated date of completion is April 2024
CJC-1295 (Modified GRF 1-29) activates GHRH receptors (GHRH-R) via the cAMP/PKA intracellular pathway
You can take the latter orally, and is suited for treating intestinal and stomach problems
Investigations into sex-specific metabolic responses, hormonal influences, and potential long-term adverse effects are crucial for refining treatment guidelines
J Pediatr 1993
US$ 25.30
US$ 29.42
US$ 25.59
